Your session is about to expire
← Back to Search
HemoPill for Gastrointestinal Bleeding
Study Summary
This trial is testing a new pill that has a built in sensor to detect if there is bleeding in the upper digestive tract. The information from the sensor is then transmitted to medical personnel.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I don't have any blockages or abnormal passages in my digestive tract.I am unable to understand or sign the consent form.I am willing and able to follow the study's procedures.I do not have trouble swallowing or any swallowing disorders.I am scheduled for an endoscopy because of suspected upper GI bleeding.I am 18 years old or older.
- Group 1: HemoPIll group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What criteria must potential participants meet for eligibility in this clinical trial?
"To be accepted into this medical study, potential participants must have upper gastrointestinal bleeding and be between 18 to 99 years old. Approximately 50 people are needed for full recruitment."
Does this trial have an age limit, and if so, what is the upper boundary?
"This medical trial can only be accessed by individuals aged between 18 and 99. Patients below the age of consent have access to 3 additional studies, while those over 65 are able to enroll in 27 distinct clinical trials."
What is the current estimated enrollment size for this research trial?
"Affirmative. According to the clinicaltrials.gov website, this medical experiment is currently seeking new participants; it was initially published on June 17th 2022 and updated as recently as August 4th 2022. This trial seeks 50 individuals from one research site."
Are there still opportunities to join this experiment?
"According to the data hosted on clinicaltrials.gov, this trial remains open for recruitment and was last updated on August 4th 2022. The initial posting date of June 17th 2022 is also noted."
Share this study with friends
Copy Link
Messenger